UPDATED – 2022 Safety Protocols

CHI has instituted mandatory health and safety protocols for all in-person participants. We are excited to bring our community back together in 2022, with trust and safety as our top priorities. All in-person participants are required to:

  • Have a negative COVID-19 test result from an FDA-authorized over-the-counter antigen test within 24 hours prior to arriving at the event. You will be asked your results at registration.

The Bioprocessing Summit 2022

For more than 10 years, The Bioprocessing Summit has been recognized as the premier forum for industry leaders to share the latest research in bioprocess R&D, scale-up, quality and analytics. As we navigate the new realities of conferences and gatherings, you can count on CHI’s commitment to deliver quality content and facilitated networking opportunities to help achieve your research goals.

Our new hybrid event model gives you the option to experience the summit in-person or online, and our flexible registration policy allows you to register with confidence.

Premier Sponsors


2022 Plenary Keynote Speakers

Advances in Vaccine Formulation and Stability

David B. Volkin, PhD

David B. Volkin, PhD
Distinguished Professor, Pharmaceutical Chemistry, University of Kansas, Lawrence

Lessons Learned
from the Pandemic

Nicholas Warne, PhD,

Nicholas Warne, PhD,
Vice President, Pharmaceutical Research and Development, BioTherapeutics Pharmaceutical Sciences, Pfizer Inc.

Emerging Platforms for New Modalities

Hari Pujar, PhD

Hari Pujar, PhD
Operating Partner, Flagship Pioneering, and Chief Operating Officer, Tessera Therapeutics

Cell and Gene Therapy (R)evolution

Mercedes Segura Gally, PhD

Mercedes Segura Gally, PhD
Vice President, Process Development, ElevateBio

Sponsorship & Exhibit Opportunities

CHI offers sponsorships which will maximize your exposure before, during and after each event.

Sponsorship Demographics Chart